ALBANJI, M. H., SURBAYA, S. H. and ALNAKHLI, O. A. (2025) “IMMUNOPATHOGENESIS AND EMERGING IMMUNOTHERAPIES IN TYPE 1 DIABETES MELLITUS: THE ROLE OF TEPLIZUMAB IN DISEASE MODULATION”, TPM – Testing, Psychometrics, Methodology in Applied Psychology, 32(S1 (2025): Posted 12 May), pp. 738–744. doi: 10.5281/zenodo.17586879.